Columbia Care strives to be as available as possible for our patients. We have locations all across the United States. Find out if there is a Columbia Care location in your area.
Our patient-centric focus includes one-on-one consultations and follow-ups with pharmacists and experts, enabling individualized care on your personal health and wellness journey.
With a focus on clean cultivation, superior quality, and positive patient outcomes, we offer brands and products that meet high standards of potency, purity, and predictability.
Our proprietary, patent-pending medical brands define Medical Cannabis. TheraCeed™, ClaraCeed™ and EleCeed™ are pharmaceutical-quality and come in a variety of formats, including hard-pressed tablets, suppositories, vapes, and lotions.
With over one million patient interactions, we’re proud of the positive outcomes we’ve helped create. For powerful stories about how Columbia Care has impacted patients’ lives, click here.
We have established partnerships with some of the world’s leading research institutions, universities, and medical schools to further medical cannabis research, allowing for timely and relevant data collection and analysis, to drive future innovation.
We analyze patient and research data to identify new insights, that enable innovation in patient care and treatment, leading to new IP and improved patient experiences.
From products to service, we innovate to provide better products, patient experiences, and better patient outcomes.
Patient access is a cornerstone of our public policy work and we believe that financial needs should not stand in the way of life-changing medical cannabis. That’s why we created Share Well/Care Well, a program that provides financial subsidies to medical patients in need.
Columbia Care is leading the fight against opioid addiction by helping to launch the #100Million initiative. Our CEO Nicholas Vita pledged to take 100 million doses of opioids off the street by leading a nationwide effort to gather the largest data set on how precisely-formulated medical cannabis can be a safe and effective alternative to reduce opioid use for pain.
From introducing the U.S.’s first legal credit card for cannabis purchases, to starting the 100 million ways to break the opioid crisis research initiative, to advocating for access for patients of all types around the U.S. and the world, we have led the way in this industry and will continue to do so for the good of our business and our patients. As an experienced multi-state operator, some of our key achievements include six-plus years of strong organic growth, 1 million patient sales transactions, 63 facilities in operation or development, and 39 licenses in 15 markets.